RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

NDT Pharmaceuticals ROCE 2024

NDT Pharmaceuticals ROCE

0

NDT Pharmaceuticals Dividend yield

Ticker

NDTP

ISIN

US63948Q1058

In 2024, NDT Pharmaceuticals's return on capital employed (ROCE) was 0, a 0% increase from the 0 ROCE in the previous year.

NDT Pharmaceuticals Aktienanalyse

What does NDT Pharmaceuticals do?

NDT Pharmaceuticals Inc is an American company that has been operating in the pharmaceutical industry for over 30 years. It was founded in 1989 by Robert Dickey and is headquartered in New Jersey. The company's focus is on the development and production of prescription drugs, as well as the manufacturing of raw materials for the pharmaceutical industry. The history of NDT Pharmaceuticals Inc dates back to its founding in 1989. Robert Dickey, the company's founder, began his career in the pharmaceutical sector in the 1970s and built his success with The Pharmaceutical Research Institute. This company was later acquired by Pfizer, and in 1989 Dickey joined NDT Pharmaceuticals Inc. At that time, the company had no products and employed only a few people. However, through the dedicated work and innovative ability of Robert Dickey and his team, the company quickly grew and became a major player in the American pharmaceutical market. The business model of NDT Pharmaceuticals Inc is focused on developing prescription drugs and successfully placing them in the market. The company relies on close collaboration with doctors and other medical professionals to best understand and meet the needs of patients. At the same time, the company heavily invests in research and development to stay up to date with the latest medical knowledge and be able to bring innovative products to the market. The company is divided into different divisions to concentrate its focus on various product parameters and meet the needs of patients. These divisions include Hoppliedarkton, which offers products for pain relief and inflammation; Sleepoprofen, which develops and produces medications to support healthy sleep; and Revitalix, which offers products to enhance quality of life based on natural ingredients such as vitamins and antioxidants. Throughout its history, NDT Pharmaceuticals Inc has brought a variety of products to the market aimed at improving health. Some of these products include Naprogesic, a medication for pain treatment during menstruation; Vivenza, an over-the-counter medication for treating sleep disorders; and Revitalift, a highly effective anti-aging complex based on natural plant extracts and vitamins. In conclusion, NDT Pharmaceuticals Inc has established an excellent reputation as a reliable provider of prescription drugs and raw materials for the pharmaceutical industry since its founding. The company relies on close collaboration with medical professionals and a high investment in research and development to develop innovative and effective products. With its different divisions and products, the company aims to improve the health and well-being of its patients. NDT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling NDT Pharmaceuticals's Return on Capital Employed (ROCE)

NDT Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing NDT Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

NDT Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in NDT Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about NDT Pharmaceuticals Stock

What is the ROCE (Return on Capital Employed) of NDT Pharmaceuticals this year?

The ROCE of NDT Pharmaceuticals is 0 undefined this year.

How has the ROCE (Return on Capital Employed) of NDT Pharmaceuticals developed compared to the previous year?

The ROCE of NDT Pharmaceuticals has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of NDT Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that NDT Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of NDT Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that NDT Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from NDT Pharmaceuticals impact the company?

An increase in the ROCE of NDT Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of NDT Pharmaceuticals affect the company?

A decrease in ROCE of NDT Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of NDT Pharmaceuticals?

Some factors that can affect NDT Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of NDT Pharmaceuticals so important for investors?

The ROCE of NDT Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can NDT Pharmaceuticals take to improve the ROCE?

To improve the ROCE, NDT Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does NDT Pharmaceuticals pay?

Over the past 12 months, NDT Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NDT Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of NDT Pharmaceuticals?

The current dividend yield of NDT Pharmaceuticals is .

When does NDT Pharmaceuticals pay dividends?

NDT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NDT Pharmaceuticals?

NDT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of NDT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NDT Pharmaceuticals located?

NDT Pharmaceuticals is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von NDT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NDT Pharmaceuticals from 5/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did NDT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/30/2024.

What was the dividend of NDT Pharmaceuticals in the year 2023?

In the year 2023, NDT Pharmaceuticals distributed 0 USD as dividends.

In which currency does NDT Pharmaceuticals pay out the dividend?

The dividends of NDT Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NDT Pharmaceuticals

Our stock analysis for NDT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NDT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.